Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coutant

Showing results (521-530 of 835) with videos related to

Pageof 84
Sort By:
Rheumatology (Oxford, England)|January 30, 2023
Detection of anti-eIF2B autoantibodies in systemic sclerosis by immunoprecipitation-mass spectrometryJean-Baptiste Vulsteke, Frédéric Coutant, David Goncalves, et al.
European Journal of Endocrinology|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatmentAudrey Vincent, Peter Kamenický, Jugurtha Berkenou, et al.
Annales De Biologie Clinique|March 3, 2017
Pituitary stalk interruption syndrome: a rare and severe cause of pituitary deficiency Laboratory diagnosis of a newborn caseThomas Boueilh, Corentin Bassi, Stéphanie Rouleau, et al.
Clinical Endocrinology|May 1, 2012
Identification and management of poor response to growth-promoting therapy in children with short staturePeter Bang, S Faisal Ahmed, Jesús Argente, et al.
Cell|May 28, 2004
The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assemblyMaud Hertzog, Carine van Heijenoort, Dominique Didry, et al.
Annals of Surgical Oncology|January 8, 2015
French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring SystemSofiane Bendifallah, Geoffroy Canlorbe, Emmanuelle Arsène, et al.
Clinical and Translational Science|September 1, 2017
LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological ProfilesYan Jin, Claire Smith, Leijun Hu, et al.
British Journal of Cancer|February 13, 2015
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?S Bendifallah, G Canlorbe, P Collinet, et al.
Clinical Pharmacology and Therapeutics|January 31, 2024
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled StudyAmita Datta-Mannan, Arie Regev, David E Coutant, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescentsRégis Coutant, Florence Boux de Casson, Stéphanie Rouleau, et al.
Pageof 84

Showing results (521-530 of 835) with videos related to

Sort By:
Pageof 84
Rheumatology (Oxford, England)|January 30, 2023
Detection of anti-eIF2B autoantibodies in systemic sclerosis by immunoprecipitation-mass spectrometryJean-Baptiste Vulsteke, Frédéric Coutant, David Goncalves, et al.
European Journal of Endocrinology|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatmentAudrey Vincent, Peter Kamenický, Jugurtha Berkenou, et al.
Annales De Biologie Clinique|March 3, 2017
Pituitary stalk interruption syndrome: a rare and severe cause of pituitary deficiency Laboratory diagnosis of a newborn caseThomas Boueilh, Corentin Bassi, Stéphanie Rouleau, et al.
Clinical Endocrinology|May 1, 2012
Identification and management of poor response to growth-promoting therapy in children with short staturePeter Bang, S Faisal Ahmed, Jesús Argente, et al.
Cell|May 28, 2004
The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assemblyMaud Hertzog, Carine van Heijenoort, Dominique Didry, et al.
Annals of Surgical Oncology|January 8, 2015
French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring SystemSofiane Bendifallah, Geoffroy Canlorbe, Emmanuelle Arsène, et al.
Clinical and Translational Science|September 1, 2017
LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological ProfilesYan Jin, Claire Smith, Leijun Hu, et al.
British Journal of Cancer|February 13, 2015
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?S Bendifallah, G Canlorbe, P Collinet, et al.
Clinical Pharmacology and Therapeutics|January 31, 2024
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled StudyAmita Datta-Mannan, Arie Regev, David E Coutant, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescentsRégis Coutant, Florence Boux de Casson, Stéphanie Rouleau, et al.
Pageof 84